ASTRA CONFERENCE 2026

Mamiko Sakata-Yanagimoto

Invited Speaker, University of Tsukuba, Ibaraki, Japan.

Mamiko Sakata-Yanagimoto, MD, PhD

• Educational Background:
2000 M.D., University of Tokyo
2007 Ph.D., University of Tokyo
• Professional Experiences:
2021-present: Professor, Department of Hematology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan. 
2024-present: Head, Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan.
• Selected Awards
2020 4th President’s Award of Japan Agency for Medical Research and Development (AMED)
2022 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology
2022 JCA-Mauvernay award, Japanese Cancer Association
2024 Women Scientist Award, Japanese Cancer Association
• Specialty and Present Interest
Malignant lymphoma, Clonal hematopoiesis, Spatial multi-omics
• Selected publications
1. Abe Y, et al., Sakata-Yanagimoto M (Corresponding author).
“Distinct follicular T cell subsets regulate lymphoma progression and outcomes.”
Cancer Cell. 43(10):1850-1865, 2025.
2. Fujisawa M, et al., Sakata-Yanagimoto M (Corresponding author).
“Clonal germinal center B cells function as a niche for T-cell lymphoma.”
Blood. 140(18):1937-1950, 2022.
3. Abe Y, Sakata-Yanagimoto M (Corresponding author), et al.
“A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling.”
Nature Cell Biology. 24(4):565-578, 2022.
4. Fukumoto K, Sakata-Yanagimoto M (Corresponding author), et al.
“VAV1 mutations contribute to development of T-cell neoplasms in mice.”
Blood. 136 (26): 3018-3032, 2020.
5. Sakata-Yanagimoto M, et al., Ogawa S, Chiba S.
“Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.”
Nature Genetics. 46 (2): 171-175, 2014.